Fundraising Fox
/Companies
Sign in

Gesynta Pharma

Stockholm, SE · 7 known investors

Find your way into Gesynta Pharma

163 people in our graph share verified history with the Gesynta Pharma team — schools, employers, funds. One of them is your warm intro.

Jonas Jendiunlockedknows Gunilla Ekström · together at Gesynta Pharma AB (overlapped)
×6knows the team · via Gesynta Pharma AB
×5knows the team · via Karolinska Institutet

Gesynta Pharma is a pharmaceutical company developing non-hormonal, anti-inflammatory drug candidates that inhibit the mPGES-1 enzyme, with a lead program in endometriosis. Its pipeline targets inflammation- and pain-related conditions across clinical development stages.

BiotechDigital HealthFemTechMedical Devices

Founders & leadership

PSPatric Stenberg
Patric StenbergFounder
GEGunilla Ekström
Gunilla EkströmFounderGunilla Ekström has held roles spanning pharmaceutical R&D, project management, and executive leadership, including positions as a drug metabolism scientist, portfolio director overseeing analgesic compounds from discovery through clinical phase 2, CEO of a virtual pharmaceutical company, and board member at multiple life sciences firms. She has experience across the full R&D value chain from small to large pharma organizations, including investor relations and strategic financing.

Investors · 7

Foreground Capital✓ confirmed by Gesynta PharmaBoston

How we know: Foreground Capital's portfolio page · the company's own site · Not right? Tell us

Hadean Ventures✓ confirmed by Gesynta PharmaOslo

How we know: Hadean Ventures's portfolio page · the company's own site · funding news · Not right? Tell us

HealthCap✓ confirmed by Gesynta PharmaStockholm

How we know: the company's own site · funding news · Not right? Tell us

Industrifonden✓ confirmed by Gesynta PharmaStockholm · $1.1M – $4.3M

How we know: Industrifonden's portfolio page · the company's own site · funding news · Not right? Tell us

XGEN Venture✓ confirmed by Gesynta PharmaMilan

How we know: the company's own site · Not right? Tell us

Catalyze Capitallisted by Catalyze CapitalAmsterdam · $1.6M

Funding

SEC filings, press & company announcements

$28M disclosed across 1 of 3 rounds · 2025

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Gesynta Pharma do?
Gesynta Pharma is a pharmaceutical company developing non-hormonal, anti-inflammatory drug candidates that inhibit the mPGES-1 enzyme, with a lead program in endometriosis. Its pipeline targets inflammation- and pain-related conditions across clinical development stages.
Who founded Gesynta Pharma?
Gesynta Pharma was founded by Patric Stenberg, Gunilla Ekström.
Who are Gesynta Pharma's investors?
Gesynta Pharma's investors include Amboy Street Ventures, Foreground Capital, Hadean Ventures, HealthCap, Industrifonden, XGEN Venture, Catalyze Capital.
How much funding has Gesynta Pharma raised?
Gesynta Pharma has disclosed $28M raised across 1 of its 3 known rounds.
Where is Gesynta Pharma headquartered?
Gesynta Pharma is headquartered in Stockholm, SE.